Sign on to a letter urging Congressional leaders to allocate opioid funding to CDC’s viral hepatitis program in FY2018.
The primary goals of the Manual are to increase advocates' knowledge about available HCV tests and treatments and to jumpstart discussions on advocacy strategies that can be used to open up affordable access for more people with HCV.
More than 60 organizations, including NVHR, signed onto a letter urging the Trump administration to invest in the Department of Health & Human Services Viral Hepatitis Action Plan
Sign a petition asking policymakers to take action against Hep C by dropping discriminatory Medicaid restrictions on Hep C treatment.
The NYC Health Department has released its 2016 Hepatitis B and C Annual Report, and this past year amended the Health Code to improve complete hepatitis C diagnostic testing and outcomes in NYC.
The NYC Health Department is proposing that the Board amend Health Code §13.03(b)(3)(A) to require laboratories to report all hepatitis B virus (Hep B) DNA test results, including negative results - please comment!
Read and provide your comments on the NYC Department of Health proposed health code amendment on HCV reflex RNA testing.
NASTAD has issued a Call to Action for an urgent response to the nation's hepatitis C epidemic.
The letter urges support for increased funding for viral hepatitis in the FY2018 appropriations bills.
The FY 2017-18 NYC Viral Hep Budget Proposal supports building on the existing success of the City’s viral hepatitis programs, including Check Hep B and C Patient Navigation Program, and Hep C Peer Navigation Program.
